{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:13:28Z","timestamp":1773339208138,"version":"3.50.1"},"reference-count":40,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2026.13110","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:16:25Z","timestamp":1771330585000},"page":"1-9","source":"Crossref","is-referenced-by-count":0,"title":["Rhabdomyolysis in a patient with lung cancer with sintilimab\u2011induced overlap syndrome and hypothyroidism: A case report"],"prefix":"10.3892","volume":"31","author":[{"given":"Bingyi","family":"Chen","sequence":"first","affiliation":[{"name":"The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Zeng","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shitong","family":"Yan","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanlin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"key20260312100959_b1-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"CD011044","key":"key20260312100959_b2-ETM-31-4-13110","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011044.pub3","article-title":"Chemotherapy and radiotherapy for advanced pancreatic cancer","volume":"12","author":"Haggstrom","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"key20260312100959_b3-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"354","DOI":"10.6004\/jnccn.2025.0043","article-title":"NCCN guidelines\u00ae insights: Non-small cell lung cancer, version 7.2025","volume":"23","author":"Riely","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"issue":"148082","key":"key20260312100959_b4-ETM-31-4-13110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.148082","article-title":"Polysaccharides of Pseudostellaria heterophylla (Miq.) Pax ex Pax et Hoffm: Extraction, purification, structural characteristics, pharmacological activities, and structure-activity relationships: A review","volume":"330","author":"Gao","year":"2025","journal-title":"Int J Biol Macromol"},{"issue":"120677","key":"key20260312100959_b5-ETM-31-4-13110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120677","article-title":"Comprehensive characterization of Rubus idaeus L. Polysaccharides: Extraction, purification, structural diversity, biological efficacy, and structure-activity relationships","volume":"355","author":"Gao","year":"2026","journal-title":"J Ethnopharmacol"},{"key":"key20260312100959_b6-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"9459","DOI":"10.2147\/IJN.S466396","article-title":"Synergistic potential of nanomedicine in prostate cancer immunotherapy: Breakthroughs and prospects","volume":"19","author":"Jiang","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"key20260312100959_b7-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/imr.13247","article-title":"Immune-related adverse events after immune check point inhibitors: Understanding the intersection with autoimmunity","volume":"318","author":"Singh","year":"2023","journal-title":"Immunol Rev"},{"key":"key20260312100959_b8-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1378\/chest.12-2016","article-title":"Rhabdomyolysis","volume":"144","author":"Zimmerman","year":"2013","journal-title":"Chest"},{"key":"key20260312100959_b9-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.rdc.2024.02.003","article-title":"Immune checkpoint inhibitor-induced myositis","volume":"50","author":"Jayan","year":"2024","journal-title":"Rheum Dis Clin North Am"},{"issue":"101192","key":"key20260312100959_b10-ETM-31-4-13110","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101192","article-title":"Features of myositis and myasthenia gravis in patients treated with immune checkpoint inhibitors: A multicentric, retrospective cohort study","volume":"50","author":"Plomp","year":"2025","journal-title":"Lancet Reg Health Eur"},{"issue":"196","key":"key20260312100959_b11-ETM-31-4-13110","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00196","article-title":"Comparison of the 7 and 8th edition of the UICC\/AJCC TNM staging system in primary resected squamous cell carcinomas of the lung-A single center analysis of 354 cases","volume":"6","author":"Neppl","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"key20260312100959_b12-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s40744-023-00540-6","article-title":"Clinical characteristics of dermatomyositis with interstitial lung disease: A retrospective case-control study","volume":"10","author":"Weng","year":"2023","journal-title":"Rheumatol Ther"},{"key":"key20260312100959_b13-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41574-022-00683-6","article-title":"Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions","volume":"18","author":"Li","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"key20260312100959_b14-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000135626","article-title":"Immune-endocrine interactions in autoimmune thyroid diseases","volume":"15","author":"Klecha","year":"2008","journal-title":"Neuroimmunomodulation"},{"issue":"e05107","key":"key20260312100959_b15-ETM-31-4-13110","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5107","article-title":"Severe hypothyroidism-induced rhabdomyolysis: A case report","volume":"9","author":"Baghi","year":"2021","journal-title":"Clin Case Rep"},{"key":"key20260312100959_b16-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1530\/JOE-16-0611","article-title":"Role of thyroid hormone in skeletal muscle physiology","volume":"236","author":"Bloise","year":"2018","journal-title":"J Endocrinol"},{"key":"key20260312100959_b17-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.cmet.2014.10.009","article-title":"Intracellular inactivation of thyroid hormone is a survival mechanism for muscle stem cell proliferation and lineage progression","volume":"20","author":"Dentice","year":"2014","journal-title":"Cell Metab"},{"issue":"bvae163.1812","key":"key20260312100959_b18-ETM-31-4-13110","article-title":"8670 Hypothyroidism impairs skeletal muscle regeneration after injury","volume":"8 (Suppl 1)","author":"Aguiari","year":"2024","journal-title":"J Endocr Soc"},{"key":"key20260312100959_b19-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1200\/JCO.2010.33.4979","article-title":"Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and Leukemia Group B trial 30407","volume":"29","author":"Govindan","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1512","key":"key20260312100959_b20-ETM-31-4-13110","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45769-z","article-title":"Sintilimab with two cycles of chemotherapy for the treatment of advanced squamous non-small cell lung cancer: A phase 2 clinical trial","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat Commun"},{"key":"key20260312100959_b21-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.jtho.2021.04.011","article-title":"Sintilimab plus platinum and gemcitabine as first-line treatment for advanced or metastatic squamous NSCLC: Results from a randomized, double-blind, phase 3 trial (ORIENT-12)","volume":"16","author":"Zhou","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"eabb7495","key":"key20260312100959_b22-ETM-31-4-13110","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb7495","article-title":"CD4+ T cells are essential for the development of destructive thyroiditis induced by anti-PD-1 antibody in thyroglobulin-immunized mice","volume":"13","author":"Yasuda","year":"2021","journal-title":"Sci Transl Med"},{"issue":"76","key":"key20260312100959_b23-ETM-31-4-13110","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-025-03547-2","article-title":"Modulating IL-21-driven B cell responses in idiopathic inflammatory myopathies via inhibition of the JAK\/STAT pathway","volume":"27","author":"Merino-Vico","year":"2025","journal-title":"Arthritis Res Ther"},{"issue":"eabf4034","key":"key20260312100959_b24-ETM-31-4-13110","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf4034","article-title":"The double-edged sword: Harnessing PD-1 blockade in tumor and autoimmunity","volume":"6","author":"Kuchroo","year":"2021","journal-title":"Sci Immunol"},{"key":"key20260312100959_b25-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"key":"key20260312100959_b26-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1152\/ajpendo.00539.2015","article-title":"Na,K-ATPase regulation in skeletal muscle","volume":"311","author":"Pirkmajer","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key20260312100959_b27-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1515\/jbcpp-2024-0139","article-title":"Effects of thyroid hormones in skeletal muscle protein turnover","volume":"35","author":"Nappi","year":"2024","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"e210031","key":"key20260312100959_b28-ETM-31-4-13110","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210031","article-title":"Immune checkpoint inhibitor myopathy: The double-edged sword of cancer immunotherapy","volume":"103","author":"Beecher","year":"2024","journal-title":"Neurology"},{"issue":"102455","key":"key20260312100959_b29-ETM-31-4-13110","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102455","article-title":"Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern","volume":"19","author":"Matas-Garc\u00eda","year":"2020","journal-title":"Autoimmun Rev"},{"key":"key20260312100959_b30-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ekir.2022.09.026","article-title":"Molecular mechanisms of rhabdomyolysis-induced kidney injury: From bench to bedside","volume":"8","author":"Hebert","year":"2022","journal-title":"Kidney Int Rep"},{"key":"key20260312100959_b31-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"379","DOI":"10.55563\/clinexprheumatol\/q7mdjs","article-title":"Immune checkpoint inhibitor-related myositis: From pathophysiology to treatment","volume":"41","author":"Sundarrajan","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"key20260312100959_b32-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/03009742.2019.1596309","article-title":"Nivolumab-induced anti-aminoacyl-tRNA synthetase antibody-positive polymyositis complicated by interstitial pneumonia in a patient with lung adenocarcinoma","volume":"49","author":"Shikano","year":"2020","journal-title":"Scand J Rheumatol"},{"key":"key20260312100959_b33-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10637-020-00974-7","article-title":"Anti-transcriptional intermediary factor 1-\u03b3 antibody-positive dermatomyositis induced by nivolumab for lung adenocarcinoma: A case report","volume":"39","author":"Osaki","year":"2021","journal-title":"Invest New Drugs"},{"issue":"3513","key":"key20260312100959_b34-ETM-31-4-13110","doi-asserted-by":"publisher","DOI":"10.57187\/s.3513","article-title":"Pembrolizumab-associated anti-MDA5 dermatomyositis in a patient with lung cancer: A first case report","volume":"154","author":"Pilia","year":"2024","journal-title":"Swiss Med Wkly"},{"key":"key20260312100959_b35-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1002\/art.40320","article-title":"2017 European league against rheumatism\/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"key20260312100959_b36-ETM-31-4-13110","author":"Kirou"},{"key":"key20260312100959_b37-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41574-024-01077-6","article-title":"Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors","volume":"21","author":"Iwama","year":"2025","journal-title":"Nat Rev Endocrinol"},{"issue":"e240328","key":"key20260312100959_b38-ETM-31-4-13110","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-24-0328","article-title":"Best practices in the management of thyroid dysfunction induced by immune checkpoint inhibitors","volume":"14","author":"Yamauchi","year":"2025","journal-title":"Eur Thyroid J"},{"issue":"1597259","key":"key20260312100959_b39-ETM-31-4-13110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1597259","article-title":"Management of immune-related myocarditis, myositis and myasthenia gravis (MMM) overlap syndrome: A single institution case series and literature review","volume":"16","author":"S\u00e1nchez-Camacho","year":"2025","journal-title":"Front Immunol"},{"key":"key20260312100959_b40-ETM-31-4-13110","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J Clin Oncol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:10:07Z","timestamp":1773303007000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2026.13110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2,17]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2026.13110","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]}}}